| Literature DB >> 15070571 |
Abstract
Migraine is a very common neurobiological headache disorder that is caused by increased excitability of the CNS. It ranks among the world's most disabling medical illnesses. Diagnosis is based on the headache's characteristics and associated symptoms. The economic and societal effect of migraine is substantial: it affects patients' quality of life and impairs work, social activities, and family life. There are many acute and preventive migraine treatments. Acute treatment is either specific (triptans and ergots) or non-specific (analgesics). Disabling migraine should be treated with triptans. Increased headache frequency is an indication for preventive treatment. Preventive treatment decreases migraine frequency and improves quality of life. More treatments are being developed, which provides hope to the many patients whose migraines remain uncontrolled.Entities:
Mesh:
Year: 2004 PMID: 15070571 DOI: 10.1016/S0140-6736(04)15440-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321